Gibson, Dunn & Crutcher represented XOMA Corporation in the transaction, and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented Daré. XOMA Corporation (NASDAQ: XOMA) announced...
XOMA’s Acquisition of Economic Interest in Three Women’s Health Assets
XOMA’s $8 Million Acquisition of DSUVIA
Gibson, Dunn & Crutcher LLP advised XOMA Corporation on the expansion of its commercial royalty and milestone portfolio with the acquisition of an economic interest in...
Royalty Pharma’s Partnership with Teva Pharmaceuticals International GmbH
Gibson, Dunn & Crutcher LLP advised Royalty Pharma in connection with its development funding. Royalty Pharma plc (Nasdaq: RPRX) and Teva Pharmaceuticals International GmbH, a subsidiary...
Sumeru Equity Partners’ C$257 Million Acquisition of Q4 Inc.
Raymond James acted as exclusive financial advisor to the Special Committee. Stifel Canada acted as independent valuator to the Special Committee. Osler, Hoskin & Harcourt LLP...